Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-07-30

Clinical Trial Update: The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the effect of oral nicotinamide on plasma phosphorus levels in peritoneal dialysis patients with hyperphosphatem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide (Niacinamide) (nicotinamide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Hyperphosphatemia | Phase 1, Phase 2 | Status: COMPLETED